Status:

UNKNOWN

Handwritten Text Production in Adults With Autism

Lead Sponsor:

Centre Hospitalier de Niort

Collaborating Sponsors:

University of Poitiers

Conditions:

Autism Spectrum Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The main objective is to assess the psycholinguistic and graphomotor characteristics of written production in patients with ASD. The secondary objectives are: * Identifying links between specific de...

Detailed Description

Context : Autism Spectrum Disorder (ASD) is one of the neurodevelopmental disorders (NDD) characterized by persistent deficits in communication and social interaction, and restricted and repetitive p...

Eligibility Criteria

Inclusion Criteria for experimental group only:

  • ASD diagnosis according to DSM-5 criteria and established by an interdisciplinary

Inclusion Criteria for both experimental and control groups:

  • Age ≥ 18 years Age ≥ 18 years and matching typical adult subjects to ASD individuals in age (plus or minus 5 years), sex, and education level
  • The person participating in the research has read, understood, and signed the study consent form
  • The person is proficient in the French language
  • The person is affiliated with a social security system

Exclusion Criteria for experimental group only:

  • Diagnosis of any other NDD than ASD (e.g., Attention Deficit Hyperactivity Disorder, Specific Learning Disorder, Language Disorder, Coordination Disorder, Intellectual Disorder)

Exclusion Criteria for control group only:

- Diagnosis of any NDD (ASD, Attention Deficit Hyperactivity Disorder, Specific Learning Disorder, Language Disorder, Coordination Disorder, Intellectual Disorder)

Exclusion Criteria for both experimental and control groups:

  • Refusal of the individual to participate in the study
  • Presence of severe visual impairment
  • Known pregnancy
  • Individual deprived of liberty
  • Individual under guardianship or curators
  • Presence of concurrent psychotropic medication treatments not stabilized, initiated within the last 2 months: antipsychotics, mood stabilizers, antiepileptics, psychostimulants, antidepressants
  • Presence of upper limb motor impairment, with or without devices
  • Presence of diagnosed neurological or psychiatric disorders (e.g., Schizophrenia Spectrum Disorder or other psychotic disorders), presence of a general or metabolic pathology known to have an impact on cognitive efficiency and/or motor skills of the individual (e.g., Epilepsy, Tics and Tourette Syndrome, Neuro-muscular Syndrome, Metabolic Neurological Syndromes, neoplasms)

Key Trial Info

Start Date :

November 29 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2025

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT06304701

Start Date

November 29 2023

End Date

May 1 2025

Last Update

March 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier de Niort

Niort, France, 79000

Handwritten Text Production in Adults With Autism | DecenTrialz